Novartis AG

NVS | NYSE

Price Alert Chart Builder DCF Calculator

$141.10

+$0.12 (+0.09%)

Sep 22, 2026, 12:03 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	54.81B	51.72B	46.66B	43.46B	43.97B	49.9B
Cost of Revenue	13.69B	12.83B	12.47B	11.58B	11.74B	15.12B
Gross Profit	41.12B	38.9B	34.19B	31.88B	32.24B	34.78B
Operating Income	17.07B	14.54B	9.77B	7.95B	10.06B	10.15B
Interest Income	374.91M	567.68M	629.24M	377.74M	71M	91M
Pretax Income	16.44B	13.64B	9.12B	7.18B	24.53B	9.88B
Net Income	14.06B	11.94B	14.85B	6.96B	24.02B	8.07B
Selling & General & Admin	13.31B	12.57B	12.52B	12.19B	12.83B	14.2B
Research & Development	10.74B	10.02B	11.37B	9.17B	8.64B	8.98B
Other Expenses	n/a	1.76B	531M	2.57B	715M	1.45B
Operating Expenses	24.05B	24.35B	24.42B	23.93B	22.18B	24.63B
Interest Expense	1.19B	1.04B	876.12M	834.62M	905M	921M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	37.74B	37.18B	36.89B	35.52B	33.92B	39.75B
Income Tax Expense	2.4B	1.7B	551M	1.13B	1.63B	1.81B
Shares Outstanding (Basic)	1.94B	2.02B	2.08B	2.18B	2.24B	2.28B
Shares Outstanding (Diluted)	1.96B	2.04B	2.09B	2.2B	2.26B	2.3B
EPS (Basic)	7.25	5.92	7.15	3.19	10.71	3.54
EPS (Diluted)	7.19	5.87	7.10	3.17	10.63	3.52
EBITDA	22.99B	20.72B	18.26B	14.68B	30.91B	17.21B
EBIT	17.63B	14.65B	9.98B	7.98B	25.32B	10.75B
Depreciation & Amortization	5.35B	6.07B	8.28B	6.71B	5.6B	6.46B